Authoring Studio definition

Authoring Studio means a party in the business of providing to a Content Provider engineering services that include recording, editing, and processing of content for incorporation into a DVD Disc.
Sample 1Sample 2Sample 3
Authoring Studio. [_] . DVD Disc Replicator" [_]
Sample 1
Authoring Studio. [ ] • “DVD Disc Replicator” [ ] • “DVD Disc Formatter Manufacturer” [ ] • “DVD Player Manufacturer” [ ] • “DVD-ROM Drive Manufacturer” [ ] • “DVD Decoder Manufacturer” (hardware and/or software) [ ] • “Descramble Module Manufacturer” (hardware and/or software) [ ] • “Authentication Chip Manufacturer for DVD-ROM Drive” [ ] • “Authenticator Manufacturer for DVD Decoder” (hardware and/or software) [ ] • "Verification Product Manufacturer" [ ]
Sample 1

Examples of Authoring Studio in a sentence

  • Such a request may be submitted directly, or through a designated Authoring Studio.

  • Each Content Provider or its designated Authoring Studio shall comply with procedures for submissions and respond to requests for processing of Disc and Title Keys as such procedures may be adopted and amended by Licensor from time to time.

  • SettingUpYourSoftware System requirements for using QuickTime VR Authoring Studio Thissectiondescribesthehardwareandsoftwareyouneed touseQuickTimeVR AuthoringStudio.

  • The photo- panoramas are created by Apple´s Quick Time VR Authoring Studio 1.1 and the programme environment is created by Macromedia Director 7.02.

  • The Committee noted that the Ministry of Youth Affairs & Sports (MoYAS) vetted the DPR of the project at Rs.20.73 crore.

  • QuickTime VR Authoring Studio is a new professional software tool based on QuickTime VR technology that allows web designers and multimedia authors to Product Update continues on page 32 Fourteen Experimental Linear PanoramasBy Michael WestmorelandThe Paris get-together was an opportunity for me to show some of the experimental linear panora-mas I have been making over the last three years, using a digital computer as the stitching agent.

  • After comparing the software the writers' chose the QuickTime VR Authoring Studio software to develop the movies.

  • QuickTime VR Authoring Studio comes as a This is a 140° section of my Taj Mahal panoramic.

  • The "QuickTime" movies were further processed in "Premiere" and The "QuickTime" VR movies were further processed in "QuickTime VR Authoring Studio".

  • Visual acuity Figure 1 Contrast-enhanced magnetic resonance image demonstrating an orbital cavernous hemangioma indenting the posterior sclera.


More Definitions of Authoring Studio

Authoring Studio. [ ] • “DVD Disc Replicator” [ ] • “CSS Disc Formatter Manufacturer” [ ] • “DVD Player Manufacturer” [ ] • “DVD Drive Manufacturer” [ ] • “CSS Decryption Module Manufacturer” [ ] • “Descrambler Manufacturer” [ ] • “Authenticator Module for DVD Drive” [ ] • “Authenticator Module for CSS Decryption Module” [ ] • “Integrated Products Manufacturer” [ ] • “Verification Product Manufacturer” [ ]
Sample 1

Related to Authoring Studio

  • Interconnection Studies means the Interconnection Feasibility Study, the System Impact Study, and the Facilities Study described in Tariff, Part IV and Tariff, Part VI. Interface Pricing Point:

  • Interconnection Study means any of the studies defined in the CAISO Tariff or, if applicable, any distribution provider’s tariff that reflect the methodology and costs to interconnect the Project to the Participating Transmission Owner’s electric grid.

  • Development Site means any parcel or lot on which exists or which is intended for building development other than the following:

  • Clinical Studies means Xxxxx 0, Xxxxx 0, Xxxxx 0, Xxxxx 3, and such other tests and studies in human subjects that are required by Applicable Law, or otherwise recommended by the Regulatory Authorities, to obtain or maintain Regulatory Approvals for a Licensed Product for one (1) or more indications, including tests or studies that are intended to expand the Product Labeling for such Licensed Product with respect to such indication.

  • Development Application means the development application identified in Item 5 of Schedule 1 and includes all plans, reports models, photomontages, material boards (as amended supplemented) submitted to the consent authority before the determination of that Development Application.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Interconnection Feasibility Study means either a Generation Interconnection Feasibility Study or Transmission Interconnection Feasibility Study.

  • Approval Application means a BLA, NDA or similar application or submission for a Product filed with a Regulatory Authority in a country or group of countries to obtain marketing approval for a biological or pharmaceutical product in that country or group of countries.

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.

  • Phase 3 Study means a clinical study of an investigational product in patients that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to obtain Regulatory Approval in any country as described in 21 C.F.R. 312.21(c), or a comparable Clinical Study prescribed by the relevant Regulatory Authority in a country other than the United States. The investigational product can be administered to patients as a single agent or in combination with other investigational or marketed agents [***]

  • Marketing Approval Application or “MAA” means a New Drug Application (or its equivalent), as defined in the U.S. Food, Drug and Cosmetic Act and the regulations promulgated thereunder, or any corresponding or similar application, registration or certification in any country.

  • Regulatory Approval Application means an application to seek regular or expedited Regulatory Approval of the Licensed Product for sale or marketing in any country(ies) or Region(s) in the Territory, as defined in the applicable Laws and filed with the Regulatory Authority of such country(ies) or Region(s).

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Research Budget has the meaning set forth in Section 3.2.

  • Development Project means a project for the development of land within a

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Generation Interconnection Feasibility Study means a study conducted by the Transmission Provider (in coordination with the affected Transmission Owner(s)) in accordance with Tariff, Part IV, section 36.2.

  • Renewal Application means a document used to collect pertinent data for renewal of permits

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Phase 4 Clinical Trial means a Clinical Study in any country which is conducted after Regulatory Approval of a product has been obtained from an appropriate Regulatory Authority, consisting of trials conducted voluntarily for enhancing marketing or scientific knowledge of an approved indication and trials conducted due to request or requirement of a Regulatory Authority.

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Development Plan has the meaning set forth in Section 3.2.